viral
respiratori
infect
cf
patient
associ
increas
morbid
short
long
term
viral
infect
greater
impact
cf
patient
compar
noncf
control
result
increas
respiratori
symptom
deterior
shwachman
radiolog
score
prolong
hospit
persist
decreas
pulmonari
function
increas
use
antibiot
higher
frequenc
exacerb
followup
addit
interact
virus
bacteria
cf
suggest
studi
observ
increas
new
bacteri
colon
rais
antipseudomon
antibodi
episod
viral
respiratori
infect
experiment
data
suggest
increas
viru
replic
impair
specif
antibacteri
defens
increas
adher
bacteria
play
role
pathogenesi
viral
respiratori
infect
cf
knowledg
role
virus
interact
bacteria
cf
lung
diseas
might
result
new
therapeut
strategi
improv
prognosi
cf
patient
cf
character
chronic
inflamm
bacteri
colon
recurr
infect
lung
result
irrevers
deterior
lung
function
earli
death
pseudomona
aeruginosa
one
import
pathogen
chronic
colon
airway
p
aeruginosa
associ
progress
irrevers
lung
diseas
besid
constitut
inflammatori
state
cf
typic
cours
exacerb
remiss
pulmonari
complaint
suggest
extern
factor
influenc
cours
respiratori
virus
known
caus
signific
morbid
infant
elderli
immunocompromis
asthma
exacerb
children
associ
viral
infect
review
summar
current
knowledg
epidemiolog
clinic
impact
viral
infect
cf
secondari
describ
experiment
data
concern
pathogenet
role
respiratori
virus
cf
pulmonari
diseas
viral
infect
often
associ
wors
respiratori
symptom
cf
patient
patient
increas
respiratori
lower
tract
symptom
viral
pathogen
detect
higher
percentag
younger
older
patient
case
pulmonari
exacerb
viru
detect
compar
stabl
clinic
condit
mani
differ
virus
report
incid
young
children
influenza
b
take
even
one
small
studi
parainfluenzaviru
found
lower
frequenc
one
studi
show
contribut
adenoviru
report
virus
studi
fail
detect
rhinoviru
probabl
use
serolog
cultur
serolog
difficult
due
larg
number
rhinoviru
subtyp
cultur
rel
insensit
polymeras
chain
reaction
pcr
eleven
time
sensit
detect
rhinovirus
children
studi
use
pcr
demonstr
rhinovirus
case
respiratori
complaint
viral
agent
like
enterovirus
epstein
barr
viru
cytomegaloviru
shown
play
role
cf
respiratori
symptom
low
frequenc
coronaviru
report
frequenc
viral
respiratori
infect
occur
equal
frequenc
cf
patient
healthi
control
sib
also
frequenc
viru
infect
seem
associ
preexist
clinic
condit
although
one
studi
report
possibl
associ
howev
clinic
impact
cf
patient
far
beyond
virusrel
morbid
healthi
control
cf
patient
viral
upper
respiratori
tract
infect
associ
lower
respiratori
tract
symptom
respiratori
virus
detect
patient
need
hospit
cf
patient
hospit
day
none
match
noncf
control
group
need
hospit
care
viral
infect
also
caus
increas
longterm
respiratori
morbid
cf
patient
rsv
infect
result
prolong
oxygen
need
mean
month
hospit
young
cf
children
sever
studi
demonstr
deterior
shwachman
score
radiolog
score
longterm
follow
viral
respiratori
infect
sever
deterior
relat
frequenc
viral
respiratori
infect
hospit
patient
viru
associ
lower
respiratori
tract
infect
frequent
pulmonari
exacerb
hospit
higher
use
antibiot
longterm
followup
compar
cf
patient
without
viru
associ
lower
respiratori
tract
infect
viral
respiratori
infect
cf
patient
associ
declin
pulmonari
function
pulmonari
function
test
perform
clinic
studi
tabl
fvc
declin
viru
associ
lower
respiratori
tract
infect
cf
patient
year
high
frequenc
viral
upper
respiratori
tract
infect
associ
larg
declin
fvc
one
studi
show
effect
fvc
rv
tlc
persist
declin
pulmonari
function
viral
infect
also
found
cf
patient
year
declin
vmaxfrc
rise
frc
especi
rsv
infect
vmaxfrc
increas
followup
healthi
control
cf
children
upper
respiratori
tract
symptom
deterior
cf
children
lower
respiratori
tract
infect
virus
frequent
isol
cf
patient
respiratori
symptom
frequenc
distribut
respiratori
virus
similar
cf
patient
control
rsv
influenza
viru
parainfluenzaviru
adenoviru
frequent
report
virus
may
underreport
technic
reason
viral
respiratori
infect
cf
patient
associ
increas
morbid
short
long
term
result
increas
respiratori
symptom
deterior
shwachman
radiolog
score
prolong
hospit
increas
use
antibiot
higher
frequenc
exacerb
followup
contrast
healthi
control
viral
infect
often
result
persist
decreas
pulmonari
function
cf
patient
airway
young
children
cf
colon
haemophilu
influenza
staphylococcu
aureu
increas
age
pseudomon
colon
vari
addit
burkholderia
cepacia
colon
older
patient
patient
bacteria
detect
sever
data
clinic
studi
suggest
interact
virus
bacteria
cf
case
new
bacteri
colon
found
viral
season
new
bacteri
colon
predominantli
occur
within
week
viral
upper
respiratori
tract
infect
specif
new
pseudomon
colon
follow
viral
upper
respiratori
tract
infect
within
week
patient
hospit
viral
lower
respiratori
tract
infect
pseudomon
colon
notic
within
month
patient
intermitt
chronic
colon
viral
infect
follow
rise
antipseudomon
antibodi
strongest
associ
viral
infect
rise
antipseudomon
antibodi
found
rsv
infect
twenti
percent
patient
develop
chronic
pseudomon
colon
previou
rsv
infect
compar
experiment
data
effect
viral
infect
cf
scarc
studi
suggest
higher
viru
replic
impair
innat
host
defens
cf
intrapulmonari
influenza
viru
titr
significantli
increas
mice
chronic
p
aeruginosa
infect
compar
control
mice
increas
viru
replic
also
found
parainfluenza
viru
infect
cf
human
airway
epitheli
cell
compar
control
increas
viru
replic
might
explain
sever
prolong
symptom
viral
infect
cf
patient
compar
healthi
control
one
possibl
caus
increas
viru
replic
viru
persist
might
reduc
product
respiratori
nitric
oxid
import
part
innat
antivir
defens
increas
product
protect
viral
infect
cf
patient
express
produc
enzym
synthas
type
consider
decreas
ifngdepend
antivir
host
defens
intact
aberr
immun
respons
viral
infect
also
found
chronic
respiratori
ill
like
asthma
might
suggest
repeat
viral
infect
lead
presenc
aberr
immun
respons
increas
viru
replic
hyperinflamm
increas
symptom
pulmonari
damag
viral
infect
might
also
facilit
infect
colon
bacteria
patient
cf
viral
infect
caus
destruct
epitheli
barrier
loss
cilia
loss
tight
junction
result
increas
permeabl
exposur
respiratori
basement
membran
lead
increas
possibl
bacteria
bind
bacteri
adher
viru
infect
cell
enhanc
bacteria
use
viral
glycoprotein
viru
induc
receptor
host
cell
membran
bacteri
receptor
studi
suggest
viral
infect
lead
modul
immun
respons
impair
specif
antibacteri
defens
chronic
p
aeruginosa
infect
mous
model
fatal
pneumonia
induc
pneumococc
infect
follow
influenza
viru
infect
absenc
viru
mice
surviv
pneumococc
superinfect
influenza
infect
caus
signific
increas
inflammatori
cell
cytokin
releas
suppress
neutrophil
function
earlier
data
suggest
interact
specif
virus
bacteria
cf
influenza
viru
seem
play
role
adher
p
aeruginosa
respiratori
epitheli
cell
uninfect
influenzainfect
murin
trachea
expos
six
differ
strain
p
aeruginosa
strain
adher
desquam
cell
infect
trachea
normal
mucosa
regener
epithelium
summari
experiment
data
suggest
increas
viru
replic
cf
result
sever
pulmonari
damag
facilit
infect
bacteria
colon
cf
lung
data
especi
human
model
necessari
elucid
role
virus
cf
lung
diseas
fig
knowledg
role
virus
cf
lung
diseas
might
result
new
therapeut
strategi
improv
prognosi
patient
cf
prevent
viral
infect
patient
cf
might
reach
activ
passiv
immun
present
annual
influenza
vaccin
advis
cf
patient
although
doubt
effect
passiv
immun
rsv
perform
paluvizumab
data
effect
cf
patient
lack
activ
vaccin
rsv
cf
patient
develop
anoth
strategi
might
inhibit
viru
replic
effect
antivir
agent
avail
amantadin
zanamivir
oseltamavir
use
influenza
viru
infect
treatment
oseltamavir
improv
surviv
mous
model
secondari
pneumococc
pneumonia
influenza
viru
infect
even
therapi
delay
day
influenza
viru
infect
ribavirin
possibl
use
rsv
plecoranil
picornavirus
besid
specif
viru
inhibitor
indic
interferon
statin
interfer
viru
replic
influenc
interact
virus
bacteria
could
next
pathway
diminish
respiratori
morbid
cf
patient
lowthreshold
use
antibiot
viral
infect
patient
cf
might
prevent
secondari
bacteri
infect
data
lack
knowledg
specif
interact
virus
bacteria
might
lead
develop
new
therapeut
option
evid
suggest
option
gener
specif
cf
effort
made
design
studi
explor
option
